Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins.

Documenti analoghi

• Thermodynamic dissection of the binding energetics of KNI-272, a potent HIV-1 protease inhibitor.
  di: Velazquez-Campoy, A., et al.
  Pubblicazione: (2000)
• Crystallization and preliminary neutron diffraction studies of HIV-1 protease cocrystallized with inhibitor KNI-272
  di: Matsumura, Hiroyoshi, et al.
  Pubblicazione: (2008)
• Metabolic Characterization of a Tripeptide Human Immunodeficiency Virus Type 1 Protease Inhibitor, KNI-272, in Rat Liver Microsomes
  di: Kiriyama, Akiko, et al.
  Pubblicazione: (1999)
• Pharmacokinetics of the Protease Inhibitor KNI-272 in Plasma and Cerebrospinal Fluid in Nonhuman Primates after Intravenous Dosing and in Human Immunodeficiency Virus-Infected Children after Intravenous and Oral Dosing
  di: Mueller, Brigitta U., et al.
  Pubblicazione: (1998)
• Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography
  di: Adachi, Motoyasu, et al.
  Pubblicazione: (2009)